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Abstract 
The	United	States	in	battling	an	opioid	epidemic,	and	rates	of	overdose	fatality	have	soared	to	record	highs.		Kentucky	is	among	the	states	with	highest	rates	of	opioid	overdose	fatality,	and	Jefferson	County	is	responsible	for	about	a	quarter	of	all	cases.	Overdose	Prevention	and	Naloxone	Distribution	(OPND)	programs	have	been	shown	to	decrease	fatality	rates	by	providing	a	medication	that	literally	reverses	opioid	overdose.	The	programs	provide	other	services	such	as	education	and	connection	to	recovery	facilities.		
Currently,	the	Kentucky	Harm	Reduction	Coalition	provides	naloxone	kits	to	the	residents	of	Jefferson	County,	but	they	do	not	have	a	regular	presence	in	the	community.	In	addition,	pharmacies	now	have	legal	authority	to	prescribe	and	dispense	naloxone,	but	this	can	come	with	a	fee	that	many	patients	may	not	be	able	to	afford.	The	Louisville	Metro	Department	of	Public	Health	and	Wellness	(LMPHW)	currently	operates	a	Syringe	Exchange	Program	(SEP)	at	five	different	locations,	totaling	thirty-seven	hours	per	week.		
In	the	current	proposal,	the	LMPHW	is	guided	by	a	Community	Advisory	Group	in	the	implementation	of	an	OPND	program,	to	operate	concurrently	with	the	SEP	over	a	three-year	period.	Participants	will	be	recruited	via	street	outreach,	as	well	as	through	emergency	department	and	community	pharmacy	referral.	We	will	use	pre-tests,	post-tests,	an	annual	fatality	reports,	and	participant	feedback	in	evaluation	for	change	and	outcomes.	If	successful,	we	ultimately	hope	to	see	a	decrease	in	opioid	overdose	fatality	rates	in	Jefferson	County.	 
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A. Population and Need  
The United states is in the midst of an opioid epidemic. From 2000 to 2015, more than 
500,000 people died from drug overdoses- 63% of which involved an opioid.1 Opioids are 
substances related to morphine that are primarily used for pain relief, although other indications 
exist. This class of drugs includes prescription pain medication, such as oxycodone, methadone, 
and fentanyl, whether obtained with a legal prescription or illegally. The illicit drug heroin is 
also an opioid.  
Kentucky consistently ranks among the states with the highest rates of drug overdose deaths. 
In 2015, Kentucky had the fourth highest age-adjusted rate of 29.9 per 100,000 (Figure 1). 
Despite numerous program and policy initiatives, the state as a whole continues to see an 
increase in annual overdose deaths. There were 1,404 such fatalities in 2016 as reported to the 
Office of Vital Statistics. This represents about a 12% increase from 1,248 in 2015.2 
 
Figure 1: Drug Overdose Mortality Rate by State, 2015 
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Jefferson County is a large, urban county located in the Northwest part of Kentucky, and it is 
by far the most populous county in the state. There are tens of cities within the county, but the 
largest and most notable is Louisville, which is the largest city in Kentucky and the 29th most 
populous city in the country. Within its 380 square miles, there were 741,096 citizens according 
to the 2010 U.S. Census. Approximately 73% of the population is white, 21% is black, and 4% is 
Hispanic or Latino. The median household income is $48,695, and 15.4% of the population is in 
poverty. Approximately 35% of the citizens over 16 years old are unemployed, and 6.8% are 
without health insurance.3 
Jefferson County has consistently ranked highest in drug overdose deaths of all 120 counties 
in Kentucky. In 2016, there were 364 cases of drug overdose mortality in Jefferson County, 
making up about a quarter of all overdose mortality cases in the state. Figure 2 displays the drug 
overdose mortality count in the state of Kentucky in 2016 by county of residence. Even based on 
county of residence, Jefferson County (the dark county in the northwest) accounted for 311 
deaths, with the next highest county being Fayette County (central) with 114.2 In addition, there 
were 8,173 (218 per 100,000) emergency department visits due to drug overdoses in Jefferson 
County from 2010-2014. This is approximately 20% of the total overdose emergency department 
visits in the state.4 Overall, the county has fairly good health status, ranked 28 of 120 overall for 
health outcomes. It does, however, have elevated rates of violent crime and HIV infection.5,6 
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Figure 2: Drug Overdose Mortality in Kentucky by County of Residence, 2016 
 
Naloxone (initially marketed under the brand name Narcan®) is a life-saving opioid antidote. 
The antidote blocks the opioid receptors in the body in order to reverse the detrimental 
neurologic and respiratory depression caused by opioids. First approved for use in the United 
States in 1971, it has a long history of use in hospitals, emergency departments, and ambulances. 
Naloxone also has very few adverse effects, apart from precipitating withdrawal symptoms from 
opioids, and is therefore safe for use even if a patient has not consumed opioids. Traditionally 
given via the intravenous, intramuscular, or subcutaneous routes, naloxone has primarily only 
been used by healthcare professionals. However, naloxone has also been used intra-nasally, with 
the first reported such use in 1991. Intranasal naloxone has proven to be as effective as 
intravenous naloxone at reversing overdose symptoms, particularly when an atomizer is used to 
ensure appropriate distribution of the drug within the nares.7 Intranasal naloxone is relatively 
easy to use, even by laypersons, offering a new potential key to decreasing opioid overdose 
mortality.  
Senate Bill 192 was passed by the Kentucky General Assembly in 2015 in an attempt to 
combat the increasing rates of opioid overdose deaths. The bill was signed by Governor Steve 
Beshear on March 25, and, as it contained an emergency clause, became immediately effective. 
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Under the new law, there were stricter penalties for heroin trafficking. However, the bill 
promoted an increased recognition of substance addiction as a health problem, and increased 
funding was provided for the state’s addiction treatment system. Naloxone availability increased, 
partially due to this funding. Pharmacists were also granted the power to (with proper training) 
prescribe and dispense the opioid antidote.8 
However, the cost of naloxone kits has risen with increasing demand. The formulation most 
commonly used for kits, a 2mg/2mL (1mg/1mL) pre-filled syringe distributed by Amphastar, 
nearly doubled in price between 2009 and 2016, with a cost of $39.60 in 2016. These can be 
used either be administered as an injection with a needle or intranasally with an atomizer, 
depending on program preference. Two syringes are included in most kits in the event that a 
second dose is needed prior to EMS arrival. A 10-milliliter multi-dose vial (0.4mg/mL) is 
available for $142, a 129% price increase since 2012. Newer, easier-to-use formulations are 
much more expensive; the two-pack auto-injector, Evzio, that was introduced in 2014 at a price 
of $690, has since increased to a price of $4,500. With these prices, pharmacies and third-party 
organizations (working in collaboration with a prescriber) are often not able to provide the 
overdose kits free of charge. Unfortunately, those with substance use disorders are often 
uninsured, unemployed, or low-income, and may not be able to afford the kits out-of-pocket.9 
There is a great need for funded programs that can provide these rescue kits at no cost to those 
who need them most.   
The Kentucky Harm Reduction Coalition already does offer naloxone training and 
distribution events in Jefferson County.  However, the location for training changes, and 
offerings are sporadic. In one calendar month (August 2017), they offered five training sessions 
for the syringe-exchange program (SEP) clients, totaling 14 hours, and offered at four different 
	 Coleman      8 
locations (they also had a training session for law enforcement and staff at the Women’s Healing 
Place).10 Table 1 outlines these training events. While offering the training at different locations 
may be advantageous for reaching a larger percentage of the population, it does not provide 
consistent access for those at each location. There have been various community-wide naloxone 
administration trainings conducted in the city, and in 2016, 5032 naloxone administrations 
occurred in Louisville (outside of the healthcare system). However, 83% of these administrations 
were performed by emergency medical services and police officers. While this does demonstrate 
eagerness of law enforcement to help, it demonstrates that there is still a great need for getting 
naloxone to individuals and caregivers.  
The Louisville Metro Syringe Exchange Program was started in June 2015 and provides new, 
sterile syringes and clean injection equipment to injection drug users (IDUs). The programs also 
properly dispose of used needles and syringes to reduce the number of these items 
inappropriately discarded in the community. The goal of such programs is to reduce the spread of 
HIV, Hepatitis C, and other blood-borne infections that tend to spread rapidly in this population. 
While there has been some controversy over the role of these programs in promoting continued 
drug use, this theory has been largely debunked due to evidence that they decrease rates of 
communicable diseases while also connecting IDUs to testing, counseling, and treatment 
resources. The program in Louisville operates primarily inside the Louisville Metro Public 
Department of Health and Wellness six days per week (all except Sunday) for three to five hours 
per day. In addition, the Department has partnered with Volunteers of America to offer the 
program from mobile units at remote sites. The complete schedule for the SEP can be found in 
Appendix A. More than 14,000 participants have been served since the program was 
implemented, with approximately 3,700 served each year.11 Between June 2015 and May 2017, 
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the program distributed a total of 841,064 syringes and collected 484,277- an overall exchange 
rate of 1.7-to-1. During this time, they also provided counseling to 24,085 walk-ins for safe 
needle use, conducted 1,120 tests for Hepatitis C and HIV/AIDS (196 of which were positive), 
referred 315 individuals for primary care/hospitals/Hepatitis C treatment/HIV treatment, and 
referred 305 individuals for substance treatment.  
There are also 105 pharmacies in Jefferson Counties currently offering naloxone training and 
distribution without a prescription, but require the patient to pay for the kits. The SEP provides 
an ideal site for implementation of a naloxone distribution program, and for the purposes of this 
grant proposal, we will assume that half of SEP participants will be interested in obtaining 
naloxone kits, with some participants requiring multiple kits. For this reason, we will plan to 
serve at least 1,500 people and distribute 2,000 kits.   
 
Table 1: KHRC Naloxone Training in August 2017 
Date Who Was Trained Location Time 
August 9 
 
SEP Clients Bicknell (Near Iroquois Family Health 
Center) 
11:00AM-
2:00PM 
August 
17 
SEP Clients Lake Dreamland Fire Department 11:00AM-
2:00PM 
August 
21 
Law Enforcement West Buechel Law Enforcement  3:00PM-
4:00PM 
August 
22 
Staff Women’s Healing Place 8:30AM-
9:30AM 
August 
24 
SEP Clients Louisville Health Department 4:00PM-
6:00PM 
August 
25 
SEP Clients Portland Health Clinic 1:00PM-
4:00PM 
August 
29 
SEP Clients Louisville Health Department 11:00AM-
2:00PM 
 
 
 
	 Coleman      10 
B. Program Approach  
The Chicago Recovery Alliance (CRA) started the first take-home naloxone program in the 
country in Cook County, Illinois. The Alliance has become one of the largest harm reduction 
programs in the world through respectful collaboration with drug users since 1992. Community 
Advisory Groups have informed the initiation and feedback of their work in prevention of HIV 
infection and other drug-related harms. One of the largest services provided by the CRA is the 
SEP. They operate van-based sites, storefront-based sites, and cell-phone based services. 
Volunteer physicians started prescribing and dispensing naloxone from the outreach vans in 
1998, and subsequently developed a four-hour curriculum for CRA outreach specialists 
regarding naloxone. The curriculum includes opioid neurophysiology, pharmacology of 
commonly used opioids, pharmacology of naloxone, risk factors and prevention techniques of 
overdose, prevention of aspiration and choking in the unconscious patient, techniques of rescue 
breathing, routes of administration and dosing guidelines for naloxone, and protocols for follow-
up care. The trained CRA staff are then able to implement an Overdose Prevention and Naloxone 
Distribution (OPND) program with the SEP participants. The CRA’s official program was 
implemented in January of 2001. 
A medical history is obtained on all participants to be prescribed naloxone. They are then 
shown or may take home a 10-minute DVD, which provides standardized curriculum on 
overdose and naloxone. The DVD also illustrates rescue breathing on a real person. In addition, 
they next partake in a brief 15-20 minute education session containing information similar to the 
DVD. These education sessions are conducted in group, pairs, or one-on-one, as needed. The 
participant is then dispensed a naloxone kit, containing a 10-milliliter multi-dose vial of 
naloxone 0.4mg/mL, a supply of sterile syringes and intramuscular needles, a pocket-sized 
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instruction card for overdose recognition and treatment, and documentation that the participant’s 
possession of the medication is legal and medically sanctioned.12 
Participants are also instructed to seek or summon emergency assistance. One reason for this 
is that the effects of naloxone only last 30-90 minutes, which is shorter than the duration of 
action of many opioids. Extra doses are included in the kits for this reason, but patients often 
require respiratory support and potentially continuous infusions of naloxone to prevent rebound 
symptoms. Naloxone also does not reverse non-opioid overdose symptoms (such as those from 
benzodiazepines, alcohol, or cocaine), so patients may need further medical attention for those 
substances. A second reason that this instruction is given is because many users are unaware of 
new laws. Senate Bill 192 (in Kentucky) has an included provision that grants immunity to users 
who report an overdose victim. It is important that users are made aware of this, so they are not 
afraid to make a life-saving intervention due to fear of legal repercussions.  
In 2006, the CRA’s outreach program directly contacted 340 drug users weekly, who then 
reached an additional 780 people. Between 2001 and 2006, the program prescribed 
approximately 3,500 10-dose vials of naloxone, and received 319 reports of peer reversals. 
Through 2011, they had provided 22,010 kits and received 2,720 such reports. The largest 
indicator of the efficacy of the distribution program was the reversal of trend in overdose deaths. 
From 1991 to 2000, the rate steadily increased, with a four-fold increase between 1996 and 2000. 
However, this rate decreased 20% in 2001, with subsequent 10% decreases in 2002 and 2003 
(Figure 2).13,14 
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Figure 3: Opioid Overdose Mortality Trends in Cook County, IL 
 
CCME: Cook County Medical Examiner  
 
Since the implementation of this program in Chicago, similar ones have been established in 
Baltimore, San Francisco, New York, and New Mexico. In fact, as of July 2014, there were at 
least 644 local OPND programs across 30 states and the District of Columbia. Based on a survey 
of managers from 136 of these sites, the majority of the programs (44.1%) utilized trained non-
medical staff and volunteers to provide kits under a standing order with a physician. 
Approximately one-third of responding programs reported difficulty obtaining naloxone.15  
Although the population size of Cook County, IL, is much higher than that of Jefferson 
County, KY, both cities are quite urbanized. The demographics are fairly similar between the 
two counties. There is a notably higher percentage of Hispanic or Latino persons in Cook 
County, and there are more white persons in Jefferson County. However, this difference is 
unlikely to require specific program adaptations. Table 2 illustrates some demographic traits 
according to 2016 United States census estimates. It is unlikely that any specific adaptations 
would be necessary from a population perspective. However, due to rising costs of naloxone, it 
would be advantageous to dispense a different formulation of the product than the 10-milliliter 
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multi-dose vial dispensed by the CRA. They were initially obtaining this formulation at $2.54/ 
vial, and have since been able to continue to pay a lesser price than other organizations since 
they are such long-standing customers. While the multi-dose vial does offer a better price per 
dose of medication, the vials are only good for use for 28 days after the first needle enters the 
vial (under sterile conditions). After that time frame, the drug may not work as well and may be 
contaminated. Therefore, a large amount of the vial may go to waste.  
 
Table 2: Demographic comparison between Jefferson and Cook counties 
Characteristic Jefferson County, KY Cook County, IL 
Population Size 765,352 5,203,499 
Persons under 18 years  22.4% 22.3% 
Persons 65 years and older 15.2% 13.6% 
White alone 72.7% 65.6% 
Black or African-American alone 21.8% 24.2% 
Hispanic or Latino alone 5.1% 25.3% 
High school graduate (age 25+) 88.9% 85.3% 
Uninsured rate (under age 65) 6.8% 10.6% 
Mean household income $48,695 $55,251 
Persons in poverty 15.4% 16.2% 
 
There has been some concern that if the needles provided with injection naloxone were used 
for other drugs, there would then be no way to prepare and administer the naloxone. Utilization 
of the intranasal route of naloxone also decreases the time to administration of the antidote, as it 
may be difficult to obtain IV access in many IDUs. Also, intranasal naloxone eliminates the 
possibility of accidental needle sticks and transmission of blood-borne pathogens.7 The efficacy 
and utility of intranasal naloxone has become more well-known and wide-spread in recent years. 
By providing the 2mg/2mL pre-filled syringes, the program could minimize waste, save money, 
and provide a simpler method of naloxone delivery that does not require needle dispensing.  
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Establishing a Community Advisory Group (CAG) is an essential component of 
implementing an effective intervention. In order to create a group of individuals that is 
representative of the community and knowledgeable about our target population, a variety of 
stakeholders will need to be recruited. This group will work to provide information, education, 
and guidance regarding the various activities of our intervention, including recruitment and 
sustainability. The group members are shown in the chart below.    
Table 3: Community Advisory Group Members 
2 local police officers 1 representative from 
the District 
Attorney’s office 
1 representative from 
the mayor’s office 
1 SEP worker 
1 Harm Reduction 
Taskforce worker 
1 WLKY news 
reporter 
1 social worker 1 emergency medical 
technician 
1 pharmacist 1 emergency 
department physician 
1 substance abuse 
treatment specialist 
2 individuals who do 
or have used drugs 
2 Caregivers 1 public housing 
representative 
  
 
In addition to the CAG, several partnerships will be required to ensure success of the OPND 
program. Primarily, a relationship must be established with a local substance abuse treatment 
center; Centerstone Kentucky will serve as out default referral center for any program participant 
wishing to seek such care. Both, the Harm Reduction Taskforce and Volunteers of America will 
be able to provide pertinent information about the population based on prior experience. It will 
be vital to partner with law enforcement to maintain legality, keep them informed as to the newer 
laws, and ensure their compliance with the program. Partnering with Louisville Metro 
Emergency Medical Services and the University Hospital Emergency Department staff will 
allow us to learn more about the population and can also provide referrals to the program. Lastly, 
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partnerships with local Colleges of Public Health will help us in recruitment of graduate 
assistants.   
                                                                                                                       
Recruitment 
High-risk participants will be identified by offering the program in conjunction with the 
Louisville SEP, which also targets IDUs. The SEP currently utilized three venues for outreach to 
potential participants. The first is street outreach, in which the SEP workers directly approach 
people in the area around each site. This can obviously be risky in dangerous areas, so it is 
important that the workers and their materials are culturally appropriate and that they respect any 
clear signs from people that they do not wish to talk. This strategy is guided by key members 
from the community advisory group and early members of the program who can help to identify 
locations and outreach strategies. Having a WLKY representative on the CAP will help to 
disseminate information about the program through the news, and we will also hope to spread the 
word with flyers and social media, as well. The second venue is emergency departments, which 
can serve as access points to identify and recruit new members for the program. Apart from 
patients admitted with obvious drug-related concerns (detoxification, wound infections, 
overdose), emergency departments can also utilize various screening tools to identify at-risk 
individuals. The last venue is in community pharmacies. Pharmacists have daily contact with the 
public, and often interact with IDUs. As such, they may be willing to speak directly with patients 
or family or distribute flyers.16 The SEP currently serves around 3,700 participants per year. 
Since we will be operating in conjunction with the SEP, we will recruit largely from their 
participant pool; we are anticipating that at least half of these participants will be interested in 
receiving a naloxone kit, with some referrals from outside sources and some participants 
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ultimately receiving more than one kit. Therefore, we have budgeted to dispense 2,000 kits 
annually.  
In order to implement this OPND program, we will need funding for materials for the 
naloxone kits and training materials for the staff and participants. The current SEP employees 
may be able to add this service into their normal activities during the SEP hours. However, it will 
be most realistic to hire two additional staff members for the program, since participant training 
can require full attention for each session. There are 38 hours total per week (26 in the primary 
site and 12 in the mobile units) that will require staffing, and the two employees can split this 
time and can also divide up the time spent at each site (primary versus mobile). It will also be 
crucial to establish a partnership with Louisville Metro Public Department of Health, as well as 
with a local physician or pharmacist to oversee the program.   
 
Sustainability 
It will be important to ensure sustainability of the OPND program. This will start with the 
beginning of development, and continue through routinization within the SEP. If the program is 
effective in reducing overdose mortality, it may receive future funding through the public health 
department. In addition, there will be sustainability within the community because, unlike other 
OPND programs currently available, this program will have a consistent and regular presence at 
the SEP sites. Participants will be encouraged to educate their relatives and friends about 
naloxone and provide them with kits, and to return for a refill when their kit has been used or 
distributed. Participants will also be encouraged to spread awareness about the program through 
word of mouth or social media. Ultimately, sustainability may depend on available resources. 
Ideally, we hope to incorporate this program into the SEP, at which point the program would 
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receive funding from the state. Until that time, we will apply for future grants if needed to 
continue to offer this service. We have demonstrated that the program could sustain on grant 
amounts even lower than this one in the future, which increases the opportunities we have to 
receive funding.  
Program fidelity will be monitored by the principal investigator. Our program manager will 
randomly visit each site twice annually to ensure that the program is being implemented 
correctly. Any discrepancies that are noted will be addressed immediately, and will be 
communicated to all staff within one week. This process will be especially helpful when 
incorporating new changes based on evaluations and feedback. The community advisory group 
will aid in keeping all materials medically accurate and culturally sensitive. In addition, safety 
protocols will be in place to protect the employees of the OPND; this protocol has been included 
in Appendix B. 
Formal evaluations of OPND programs are sparse. Therefore, it will be crucial to disseminate 
the data and conclusions from this program so that other organizations will be able to duplicate 
the efforts implemented in Jefferson County. This will be accomplished via press releases and 
research reports in journals such as the American Journal of Public Health and the Journal of 
Addiction Medicine. 
 
C. Performance Measures and Evaluation 
The primary outcome that will be used to evaluate the effectiveness of the OPND program is 
the overdose mortality rate in Jefferson County, as this is the outcome the program is designed to 
improve. In order to determine the effect that the intervention has on the mortality rate, it will be 
important to know not only the rate prior to implementation, but also the trend over the past 
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several years. The trend is particularly important because a decrease in rates after 
implementation might be reflective of an on-going trend, rather than a direct effect from the 
program.  
An interrupted time series design will be used to evaluate the changes in mortality rate. The 
Office of Drug Control Policy, in cooperation with the Kentucky Medical Examiners Office, 
prepares an annual Overdose Fatality Report each June detailing county-specific drug overdose 
fatalities for the previous year. The rate of drug overdose mortality in Jefferson County will be 
recorded for the 5 years leading up to the intervention and annually afterwards. Using a scatter 
plot, a hypothetical scenario, or counterfactual, will be created for the time following the 
intervention to demonstrate a predicted rate of mortality change if the intervention were not 
implemented. The actual rate of mortality change following the intervention will also be 
observed and plotted. If the intervention has a causal impact on the rate, the post-intervention 
trend will have a different slope than that of the predicted trend based on pre-intervention values. 
It is also important to note that the intervention may have a delayed effect on the overdose 
mortality rates, so it may not be immediately apparent.17 
The benefit of the interrupted time series design is that it is a quasi-experimental design that 
will allow for evaluation of true causation of the intervention on the desired outcome. It will help 
to control for confounding factors that may also be influencing the mortality rates in Jefferson 
County. It will also be simple to undertake, and will require minimal resources. The largest 
challenge to the design is that it is prone to some decreases in internal validity due to inability to 
differentiate factors that may be influencing the outcome concurrently. To account for this 
weakness, it will be important to be cognizant of other interventions and policy changes 
happening in Jefferson County so as to determine if those might introduce bias into the results 
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from the evaluation. As mentioned previously, another challenge is that there may be a delayed 
effect from the intervention rather than an immediate one. Therefore, the rates should be 
observed for several years after the intervention, and an initial lack of change should not be 
interpreted as a program failure. Secondary outcomes will include changes in knowledge and 
awareness of the Good Samaritan Law. 
The Office of Drug Control Policy, in cooperation with the Kentucky Medical 
Examiner’s Office, prepares an annual Overdose Fatality Report each June detailing county-
specific drug overdose fatalities for the previous year. The rate of drug overdose mortality in 
Jefferson County will be recorded for the 5 years leading up to the intervention and annually 
afterwards, which will provide the information needed to determine the effect of the program on 
the primary outcome. The largest challenge to the chosen study design is that it is prone to 
decreased internal validity due to inability to differentiate factors that may be influencing the 
outcome concurrently. To account for this weakness, it will be important to be cognizant of other 
interventions and policy changes happening in Jefferson County so as to determine if those might 
introduce bias into the results from the evaluation. Another challenge is that there may be a 
delayed effect from the intervention rather than an immediate one. Therefore, the rates should be 
observed for several years after the intervention, and an initial lack of change should not be 
interpreted as a program failure.   
To evaluate the secondary outcomes, a short survey will be given in a pre-test, post-test 
format. The pre-test will be administered verbally by the graduate student when the naloxone kit 
is initially issued- before the training is provided. Demographic information will be collected, 
including age, gender, ethnicity, and race. A brief medical history will be obtained and 
participants will be asked about their substance use history. They will also be asked questions 
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regarding their baseline knowledge of opioids and overdose, self-efficacy, and attitudes 
regarding calling for help. The post-test will be administered when participants return for a new 
kit, and will re-assess those questions from the pre-test and also include questions about their 
naloxone experience. Each participant will receive a $5 Kroger gift card incentive each time they 
complete a survey. This amount is substantial enough to serve as an effective incentive, although 
small enough to avoid coerciveness. A gift card ensures that the incentive can be used for 
necessary items such as food or gas. The post-test will be offered each time a participant returns. 
It is important to note that our results could potentially be biased in offering post-tests in this 
way. If participants do not return after using their kit, we will not know if and how it was used. 
However, this is the most realistic way to gather information from this population, as many of 
them may not have phones. 
In order to assess changes in knowledge, a 16-item instrument known as the Brief Opioid 
Overdose Knowledge (BOOK) questionnaire will be administered. The BOOK is a 3-factor scale 
that represents opioid knowledge, opioid overdose knowledge, and opioid overdose response 
knowledge. The scale has demonstrated strong internal and face validity in patients with chronic 
pain and illicit drug users18,19. A copy of the measure can be found in Appendix C. One question 
will be added to this instrument regarding awareness of the Good Samaritan Law.  
 
Table 4: Measure Characteristics for the BOOK Questionnaire 
Name of selected measure: Brief Opioid Overdose Knowledge (BOOK) 
questionnaire  
Citation(s) for original articles 
reporting the development of the 
instrument and/or assessment of its 
reliability and/or validity 
Dunn et al. Brief Opioid Overdose Knowledge 
(BOOK): A questionnaire to assess overdose 
knowledge in individuals who use illicit or prescribed 
opioids. Journal of Addiction Medicine. 2016 Sept; 
10 (1), 314-323. 
Construct this instrument measures: Knowledge 
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Brief description of the measure: This measure is a brief, knowledge-based 
questionnaire to assess understanding of opioid risk 
and response to overdose. It provides a standardized 
method to evaluate knowledge gaps to inform further 
learning needs in laypersons with illicit or licit opioid 
use.  
Target population: Adults over the age of 18 using illicit or licit opioids 
who are fluent in English 
How is it administered?: Self Report Questionnaire 
Number of items: 12 
Response category format: True/False/Don’t know  
Evidence for validity: CFI = 0.964 
TLI = 0.954 
RMSEA = 0.052 [95% CI 0.000–0.083] 
 
Evidence for reliability: Not available   
Additional psychometric properties: No 
Is a scoring algorithm provided by its 
authors?: 
Yes 
Is the measure publicly available?: Yes 
Is the measure available for 
download? If so, from where?: 
Yes, online from PubMed  
 
The Principal Investigator will perform a process evaluation around six months after the 
initiation of the OPND program to ensure that the planned structure of the program is efficient. 
The MPH graduate students will be instructed to collect information from potential participants 
who decline naloxone kits as to why they may not be interested, and will report these details to 
the PI. The PI will also evaluate any post-surveys available at this time to confirm the efficacy of 
the proposed training sessions. This process evaluation will be completed every six months 
thereafter. In addition, the PI will also perform an outcome evaluation annually and compose a 
report of the number of naloxone kits distributed, scores on post-tests, and change in Jefferson 
County mortality rates per the Overdose Fatality Report. 
 
	 Coleman      22 
D. Capacity and Experience 
 The Louisville Department of Public Health and Wellness (LMPHW) is one of the oldest 
health departments in the United States, operating in some capacity since 1866. Their vision is to 
“Create a healthy Metro Louisville by decreasing disease and death, eliminating disparities in 
health and healthcare, and giving everyone the chance to live a healthy life.”  The LMPHW 
demonstrated a high capacity for serving hard-to-reach populations such as those that will be 
helped through the OPND program. Primarily, the department successfully implemented the SEP 
in June of 2015, which has served more than 14,000 participants. In addition, we have also 
maintained a Methadone/Opiate Rehabilitation and Education (MORE) Center for nearly thirty 
years, and the Center served 320 clients during the 2016 fiscal year. The department is 
continuously involved in numerous other programs targeting clinical service provision, 
community health, environmental health, and emergency preparedness. Our department and 
members have great interest in bridging the link between public health and medicine, and is 
therefore an ideal venue for implementation of a program such as the OPND program. The SEP 
is also a beneficial program to partner this program with. As described in the “Population and 
Need” section of this proposal, the SEP has had many successes in just a few short years of 
operation. Having the same target population will ensure that our interests align, and the SEP 
will likely bring support to the CAG that otherwise may not exist. 
Our board leadership is committed to reducing overdose mortality in Jefferson County. Dr. 
Sarah Smith and Matt Miller have already demonstrated a commitment to improving health 
outcomes in IDUs through their past and current roles within the SEP. Dr. Smith’s current 
position as director of the LMPHW will help with implementation and sustainability of the 
OPND program.  
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The department’s strategic plan is guided by the National Association of County and City 
Health Officials (NACCHO) Local Health Department Self-Assessment. The self-assessment is 
re-done periodically to ensure that initiatives are improving delivery of essential services. The 
Office of Policy Planning and Evaluation monitors the health status of the community and 
performs quality improvement activities to inform future health policies and plans. We have 
developed a Healthy Louisville 2020 plan, which includes a goal of reducing the death rate 
caused by overdose. The department conducts a Community Health Needs Assessment with 
local hospitals every three years, the last of which was in 2015. From 2013-2015, we conducted 
our own Behavioral Risk Factor Surveillance System (BRFSS). We also produce an annual 
report detailing all services provided per fiscal year and a Health Equity Report that is published 
every three years. During the 2017 fiscal year, the approved budget was $23,195,600, which the 
department met. We collaborated with 30 community partners, which generated over $30 million 
in grant funding for the city.  
Finally, per the Louisville Metro Government Personnel Policy 1.4, the LMPHW does not 
and shall not discriminate on the basis of race, color, religion, gender, gender expression, age, 
national origin, disability, marital status, sexual orientation, or military status, in any of its 
activities or operations. These activities include, but are not limited to, hiring and firing of staff, 
selection of volunteers and vendors, and provision of services. If the membership of LMPHW 
discovers that any member on an outreach project is in violation of this policy, that member shall 
be permanently banned from the organization and removed from the project. 
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E. Partnerships and Collaborations 
Community partnerships will be vital to the success of the OPND program. Our program 
has gained support from several partners through various groups such as non-profit and 
government agencies. Fortunately, many of the partners have also previously demonstrated 
support for the SEP.  
 
 
Table 5: Partnerships and Collaborations 
Organization Relevant Expertise   Roles 
Metro Louisville 
Harm Reduction 
Taskforce 
Opioid overdose 
management; current 
naloxone supplier to 
area 
The Metro Louisville Harm Reduction 
Taskforce is the local branch of the Kentucky 
Harm Reduction Coalition (KYHRC). The 
purpose of this coalition is to educate, train, 
empower, and engage the community and 
active users about the benefits of naloxone and 
safe needed exchange in the harm reduction 
process. The taskforce is the current supplier 
of naloxone to the Jefferson County area, and 
so will be able to provide insight about 
working with the target population, along with 
any feedback that they have received from 
participants.  
Volunteers of 
America 
Experience working 
with target 
population 
Volunteers of America currently operates the 
mobile SEP sites. As such, they have 
invaluable experience working with the target 
population. It will be crucial to form strong 
relationships with this group so that the OPND 
program will be able to work through their 
mobile units as well.  
Louisville Metro 
Police Department 
and Department of 
Corrections 
Opioid overdose 
management; law 
enforcement 
It will be important to involve local law 
enforcement in the process of establishing the 
OPND program, so as to maintain legality 
throughout the process, while also ensuring 
their compliance in the overdose reversal 
process (including the Good Samaritan law).  
Louisville Metro 
Emergency Medical 
Services (EMS) and 
University Hospital 
Emergency 
Department 
Opioid overdose 
management 
The EMS and Emergency Department will be 
able to provide input regarding the target 
population. They will be valuable stakeholders 
as an uptake in outpatient naloxone use could 
impact their workflow. They can also provide 
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information to patients regarding the OPND 
program, among other services.  
Centerstone 
Kentucky (formerly 
The Seven County 
Services, Inc., 
Jefferson Alcohol 
and Drug Abuse 
Center)  
Mental health care 
and substance abuse 
treatment 
Participants will be educated on addiction 
treatment options and referred to appropriate 
treatment upon request. Centerstone has 
currently assigned an addictions treatment case 
manager to the SEP whose responsibility is to 
inform participants and make treatment 
referrals. This case manager has agreed to also 
work with participants seeking treatment 
through the OPND program.  
University of 
Louisville School of 
Public Health and 
Information Sciences 
and University of 
Kentucky College of 
Public Health 
Education Partnerships with the major Colleges of Public 
Health will be necessary to ensure that the 
OPND program will be fully staffed. The 
Colleges will distribute information regarding 
the practicum opportunity to interested 
graduate students.  
 
F. Project Management 
While the OPND program does not require a large staff, it will be imperative to recruit 
dedicated personnel who have familiarity with the subject matter of the program, as well as with 
the target population. The Principal Investigator and Program Director are both currently 
integrated into this community through the SEP. We will also hire a program manager and two 
MPH graduate students to staff the physical distribution sessions.  
Dr. Sarah Smith, Principal Investigator: Dr. Smith obtained her MPH from Dartmouth 
College in 2006, followed by her Medical training from Temple University and residency at 
Wake Forest University. She currently practices as a board-certified family physician, and is also 
the director of the Louisville Metro Department of Public Health and Wellness. Previously 
serving as the Medical Director and Chief Health Strategist, she has already helped to expand the 
city’s smoke-free ordinance and to establish the current Syringe Exchange Program. Dr. Smith 
will have primary responsibility for the program and its implementation, and will also provide 
	 Coleman      26 
financial oversight. As a practicing Medical Doctor, she will sign off on all the naloxone 
prescriptions to fulfill legal requirements.  
TBD, Program Manager: One individual will be recruited to manage the OPND program. 
This individual should have a bachelor’s or master’s degree in public health, and should have 
prior experience in program implementation. They will facilitate Dr. Smith in oversight of the 
program, and will be responsible for site visits. They will also ensure that naloxone prescriptions 
are signed and filed appropriately. Additionally, they will provide any counseling needs to the 
program. 
The program manager  
Matt Miller, Program Director: Mr. Miller obtained his Bachelor of Science in Biblical 
Studies from Johnson University in 2004. He is a Certified Alcohol and Drug Counselor 
(CDAC) and is currently the Harm Reduction and Community Outreach Specialist for the 
Louisville Metro Department of Public Health and Wellness and the needle exchange counselor 
for the SEP. He previously served as the senior substance abuse counselor for the 
Methadone/Opioid Rehabilitation and Education (MORE) Center in Louisville. Mr. Miller will 
provide immediate oversight of the program on-site, and will help to orient the MPH graduate 
students to the community. He will address any immediate concerns that are presented through 
the program, and will also prepare the annual evaluation report utilizing the Kentucky Overdose 
Fatality Report. 
Two MPH graduate students will be recruited to staff the daily naloxone distribution 
alongside the SEP. As mentioned previously, the program will operate 38 hours per week, with 
25 hours in the primary site and 12 hours in the mobile units. The graduate students will each be 
hired for 20 hours/ week, with some additional time for preparation and data compilation each 
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day. The students will be responsible for maintaining a log of each kit dispensed, including to 
whom it was dispensed. They will also oversee naloxone training to the recipients and will 
inquire about and document successful (or unsuccessful) overdose reversals when participants 
present for a new kit. 
All staff will be adequately trained and prepared to fulfill their roles and responsibilities. 
There will be a 4-hour training session at the beginning of the project, with a 2-hour refresher 
training session annually. These sessions will encompass both, personal responsibilities and 
opioid-specific training. After the first session, there will also be time allotted to program 
updates. There will also be an opportunity to voice concerns at the end so that we are able to 
ensure continued employee satisfaction throughout the program. 
 
Figure 4: Management Structure for the OPND Program 
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Appendix A 
Louisville Metro Syringe Exchange Program: 
Locations and Hours of Operation 
 
 
Main Site: Louisville Metro Department of Public Health & Wellness 
 
Day Hours 
Sunday Closed 
Monday 11:00AM to 4:00PM 
Tuesday 1:00PM to 6:00PM 
Wednesday 1:00PM to 6:00PM 
Thursday 3:00PM to 6:00PM 
Friday 11:00AM to 4:00PM 
Saturday 11:00AM to 2:00PM 
 
 
Community Syringe Exchange Sites 
 
Site Day Hours 
Redeemer Lutheran Church Tuesday 10:00AM to 1:00PM 
Bicknell (near Iriquois Family 
Health Center) 
Wednesday 11:00AM to 2:00PM 
Lake Dreamland Fire Station Thursday 11:00AM to 2:00PM 
Portland Family Health 
Center (started 7/7/2017) 
Friday 1:00PM to 4:00PM 
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Appendix B 
Employee Safety Protocol 
1. Safety within the OPND program will be a priority.  
2. There must be a telephone available to program staff during all program sessions.  
3. Staff should have some education in conflict resolution and de-escalation.  
4. Violent acts or any threat of violence will not be tolerated, and OPND staff have the 
prerogative to cancel or close program services in the event of any occurrence affecting 
safety, security, confidentiality, or effectiveness of a session.  
a) Individuals are not allowed to carry weapons onto, or near, the SEP/OPND 
location. 
b) Weapons may include, but are not limited to, large or sharp sticks, knives, guns, 
or any device or object presented in a threatening manner;  
c) Should an individual be seen or otherwise discovered to carry a weapon, they 
should be respectfully asked to leave immediately and return without the weapon;  
d) A hostile or agitated individual bearing a weapon should not be directly 
confronted;  
e) If a person refuses to leave after being asked, it is appropriate to refuse services;  
f) If threats or acts of violence occur, the OPND should shut down immediately, 
with all other clients and staff directed to leave the location; and,  
g) If any acts of violence occur, law enforcement should be notified immediately:  
1. OPND staff must not interfere or obstruct law enforcement personnel in 
the course of their duties;  
2. All violent acts, incidents involving law enforcement agents, and arrests of 
OPND clients, staff, or volunteers during program hours must be reported 
to the PI within 72 hours. 
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Appendix C 
Brief Opioid Overdose Knowledge (BOOK) Questionnaire 
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Appendix D 
Logic Model for the OPND Program 
 
 
 
 
 
 
 
 
 
 
Inputs Activities Outputs/Outcomes 
 
• Research- base 
 
• Money/funding 
 
• Naloxone kits 
 
• Staff (primarily 
from the SEP) 
 
• Space in 
LMPHW and 
Volunteers of 
America vans to 
operate out of 
 
• Outreach 
specialist 
training 
materials 
 
• Participant 
training 
materials 
 
 
• Staff will be trained 
based on CRA 
guidelines  
 
• High-risk 
participants will be 
identified by offering 
the program at a 
location where this 
population will already 
be located 
 
• Participants will 
attend a brief training 
session and obtain a 
naloxone kit 
 
• Evaluate 
effectiveness of 
naloxone training 
sessions 
Short 
 
• Participants 
will have more 
self-efficacy in 
detecting an 
OD in their 
peers 
  
• Participants 
will have more 
self-efficacy in 
utilizing 
naloxone to 
reverse an OD 
in their peers 
 
• Participants 
will have a 
heightened 
awareness of 
Good 
Samaritan laws  
 
• Participants 
will have more 
self-efficacy in 
teaching their 
friends and 
family about 
naloxone  
Medium 
 
• Naloxone 
will be used 
by participants 
or their 
friends/family 
to reverse 
opioid OD  
 
• More 
members of 
the community 
will present to 
the ED or call 
9-1-1 for ODs 
 
Long 
 
• Jefferson 
Co. will have 
lower rates of 
drug 
overdose-
related deaths  
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Appendix E 
Gantt Chart for the OPND Program 
 
Task Year 1 (2018-
2019) 
Year 2 (2019-2020) Year 3 (2020-
2021) 
 Aug 
1 - 
Dec 
31 
Jan 
1 - 
Apr 
30 
May 
1 -  
Jul 
31 
Aug 
1 - 
Dec 
31 
Jan 
1 - 
Apr 
30 
May 
1 -  
Jul 
31 
Aug 
1 - 
Dec 
31 
Jan 
1 - 
Apr 
30 
Ma
y 1 
-  
Jul 
31 
Purchase all materials 
for naloxone kits and 
assemble  
X X X X X X X X X 
Obtain Kroger gift 
card incentives 
X         
Hire two graduate 
assistants  
X         
Initial staff training in 
Louisville, KY 
X         
“Refresher” staff 
training in Louisville, 
KY 
   X   X   
Develop culturally-
appropriate patient 
training materials  
X         
Periodically review 
appropriateness of 
patient training 
materials  
  X   X   X 
Perform process 
evaluation 
 X  X  X  X  
Offer pre/post surveys 
to all participants  
X X X X X X X X X 
Evaluate overdose 
fatality trends prior to 
initiation of program 
X         
Conduct annual 
evaluation (OD 
Fatality Report 
released in June) 
  X   X   X 
Preparation of 
manuscripts; 
presentation at 
national conference 
        X 
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Appendix F 
Budget Justification 
 
A. Salaries and Wages 
Year 1 
Position Title and 
Name 
Annual 
Salary 
% FTE Salary 
Requested 
Fringe 
Requested 
Total 
Requested 
Principal Investigator 
Sarah Smith, MD, 
MPH 
$125,000 20% $25,000 $7,461 $32,461 
Project Manager 
(vacant) 
$90,000 50% $45,000 $14,935 $59,935 
Program Director 
Matt Miller 
$60,000 100% $60,000 $23,495 $83,495 
Graduate Research 
Assistant (vacant) 
$32,000 50% $16,000 $3,916 $19,916 
Graduate Research 
Assistant (vacant) 
$32,000 50% $16,000 $3,916 $19,916 
Total Personnel   $162,000 $53,723 $215,723 
 
Year 2* 
Position Title 
and Name 
Annual Salary % 
FTE 
Salary 
Requested 
Fringe 
Requested 
Total 
Requested 
Principal 
Investigator 
Sarah Smith, 
MD, MPH 
$129,199 10% $12,920 $3,852 $16,722 
Project Manager 
(vacant) 
$98,256 50% $49,128 $15,973 $65,101 
Program 
Director 
Matt Miller 
$63,972 100% $63,972 $24,661 $88,634 
Graduate 
Research 
Assistant 
(vacant) 
$32,000 50% $16,000 $3,916 $19,916 
Graduate 
Research 
Assistant 
(vacant) 
$32,000 50% $16,000 $3,916 $19,916 
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Total Personnel   $158,020 $52,318 $210,338 
*Annual salary raise reflected  
Year 3* 
Position Title 
and Name 
Annual 
Salary 
% 
FTE 
Salary 
Requested 
Fringe 
Requested 
Total 
Requested 
Principal 
Investigator 
Sarah Smith, MD, 
MPH 
$133,075 10% $13,307 $3,968 $17,275 
Project Manager 
(vacant) 
$101,204 50% $50,602 $16,452 $67,054 
Program Director 
Matt Miller 
$65,891 100% $65,891 $25,401 $91,293 
Graduate 
Research 
Assistant (vacant) 
$32,000 50% $16,000 $3,916 $19,916 
Graduate 
Research 
Assistant (vacant) 
$32,000 50% $16,000 $3,916 $19,916 
Total Personnel   $161,800 $53,653 $215,453 
*Annual salary raise reflected  
Sarah Smith, MD, MPH, Principal Investigator (50% effort, 6 months, Years 1-3). Dr. 
Smith obtained her MPH from Dartmouth College in 2006, followed by her Medical training 
from Temple University and residency at Wake Forest University. She currently practices as a 
board-certified family physician, and is also the director of the Louisville Metro Department of 
Public Health and Wellness. Previously serving as the Medical Director and Chief Health 
Strategist, she has already helped to expand the city’s smoke-free ordinance and to establish the 
current Syringe Exchange Program. Dr. Smith will have primary responsibility for the program 
and its implementation, and will also provide financial oversight. As a practicing Medical 
Doctor, she will sign off on all the naloxone prescriptions to fulfill legal requirements. 
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Matt Miller, Program Director (100% effort, 12 months, Years 1-3). Mr. Miller obtained his 
Bachelor of Science in Biblical Studies from Johnson University in 2004. He is a Certified 
Alcohol and Drug Counselor (CDAC) and is currently the Harm Reduction and Community 
Outreach Specialist for the Louisville Metro Department of Public Health and Wellness and the 
needle exchange counselor for the SEP. He previously served as the senior substance abuse 
counselor for the Methadone/Opioid Rehabilitation and Education (MORE) Center in Louisville. 
Mr. Miller will provide immediate oversight of the program on-site, and will help to orient the 
MPH graduate students to the community. He will address any immediate concerns that are 
presented through the program, and will also prepare the annual evaluation report utilizing the 
Kentucky Overdose Fatality Report. 
 
TBN, Graduate Research Assistants (50% effort, 6 months, Year 1-3). Two MPH graduate 
students will be hired for 20 hours per week. He/she will work out of the primary SEP site and 
the mobile SEP sites to distribute naloxone and educate the recipients based on the provided 
training materials. He/she will also be responsible for maintaining a log of each kit dispensed, 
including to whom it was dispensed. They will also inquire about and document successful or 
unsuccessful overdose reversals when participants present for a new kit.  
 
Fringe Benefits: Please note that personnel fringe costs vary based on the following benefits 
schedule, which can also be found at http://www.research.uky.edu/ospa/info.html. Fringe 
benefits are escalated as described in the link. 
 
Fringe Benefits Calculations 
Benefit Staff Graduate Students 
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Retirement 10% N/A 
Social Security 7.65% 7.65% 
Other Fringe 3.6% 1.2% 
Total Percent 21.25% 8.85% 
Health/Life Insurance 
Employee $5,688/year $2,166/year 
 
B. Supplies 
Item 
Requested 
Number 
Needed 
Unit Cost Year 1 
Amount 
Requested 
Year 2 
Amount 
Requested 
Year 3 
Amount 
Requested 
Laptop 
computers 
2 $1,000 $2,000 $0 $0 
Printer 1 $100 $100 $0 $0 
Office 
Supplies 
N/A N/A $100 $100 $100 
Naloxone 
2mg/2mL 
syringes (2 per 
kit) 
2,000 kits 
per year 
$79.20 $158,400 $158,400 $158,400 
Nasal 
atomizers (2 
per kit) 
2,000 kits 
per year 
$13.04 $26,080 $26,080 $26,080 
Nitrile gloves 2,000 kits 
per year 
$0.11 $220 $220 $220 
Rescue 
breathing mask 
2,000 kits 
per year 
$1.79 $3,580 $3,580 $3,580 
Bag to contain 
materials 
2,000 kits 
per year 
$1.67 $3,340 $3,340 $3,340 
Printer 
paper/ink for 
educational 
materials 
2,000 kits 
per year 
 $400 $400 $400 
Total supplies   $194,220 $192,120 $192,120 
 
One significant expenditure of this program will be the naloxone kits themselves. We are 
projecting that around half of the SEP participants will receive a naloxone kit, and that some may 
even receive multiples. For these reasons, we are budgeting for 2,000 kits per year. A summary 
of the materials and their respective prices is listed above. Other supplies that we will need to 
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acquire include two laptops (one for each assistant, estimated as $1000 each), a printer, and 
office supplies (including pens, paper, paper clips, stapler, staples, etc., estimated to cost $100 
per year).  
 
C. Travel 
Year 1 Year 2 Year 3 
In-state Travel 
$200 $200 $200 
Out-of-state Travel 
$7,620 $10,620 $10,620 
 
The only in-state travel that we request funding for is the site visits for fidelity 
monitoring. We wish to present our findings at a minimum of two national conferences per year, 
and request travel funds for our Principal Investigator and Program Director to attend these 
conferences. With two visits annually to five different sites, the program manager will need to 
complete ten of these visits each year. The American Public Health Association (APHA) annual 
conference is held each Fall in Atlanta, GA, and would entail flight and four nights in a hotel 
room. Additionally, given the nature of our work, we wish to attend the SAMHSA National 
Leadership Forum and Prevention Day, which is held each Spring in Washington, DC. 
Attendance at this conference would entail flight and three nights in a hotel room. We will also 
have the program director attend an annual program director meeting in Washington, DC and 
will have three people (the principal investigator, program director, and one of the graduate 
students) attend regional training in years two and three. We will take each graduate student to 
one training session. Total meeting expenses are outlined below. 
 
APHA Annual Meeting 
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Airfare $400 
Lodging $200/night x 4 nights = $800 
Registration $515 
Number of attendees 2 
Total $3,030 
 
SAMHSA National Forum 
Airfare $400 
Lodging $200/night x 3 nights = $600 
Registration $595 
Number of attendees 2 
Total $3,190 
 
Annual Program Director Meeting 
Airfare $400 
Lodging $200/night x 3 nights = $600 
Registration N/A 
Number of attendees 1 
Total $1,000 
 
Annual Regional Training (years 2 & 3) 
Airfare $400 
Lodging $200/night x 3 nights = $600 
Registration N/A 
Number of attendees 3 
Total $3,000 
 
D. Other 
 Year 1 Year 2 Year 3 
Tuition for MPH Grads $28,000 $30,800 $33,880 
Survey Incentives $10,000 $10,000 $10,000 
Initial Training Session $250 N/A N/A 
Refresher Training Session N/A $150 $150 
 
Tuition is requested for the two graduate research assistants in accordance with the 
University of Kentucky’s policy for tuition remission. Tuition estimates are used based on 
current rates and projected 10% increases each year.  
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In order to incentivize participation in the program, we request to provide $5 Kroger gift 
cards for any participant who completes our survey. We have requested funding for 2,000 gift 
cards per year, totaling $10,000. 
Additionally, we need to provide training for our staff. We will provide a 4-hour training 
session at the beginning of the program, which will provide education about substance abuse and 
naloxone, along with general role-specific responsibilities. Afterwards, we will have an annual 
abbreviated, ‘refresher’ training course (2 hours) to ensure that staff stay up-to-date on the 
subject matter. Costs for the training include room reservation ($50 per hour) and food.  
  
 Year 1 Year 2   Year 3 
A. Personnel (with 
fringe) 
$215,723 $210,338 $215,453 
B. Supplies $194,220 $192,120 $192,120 
C. Travel $7,820 $10,820 $10,820 
D. Other $38,250 $40,950 $44,030 
Total $456,013 $454,228 $462,423 
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